TX Houston의 골수섬유증 임상 시험
골수섬유증 관련 연구 20개가 Houston 및 인근(약 30마일 이내) 지역에서 참여자를 모집하고 있습니다. 연구 항목을 열어 참여 자격 및 연구 팀 연락처를 확인하세요.
공식 연구 텍스트(영어)
연구 대상자를 모집 중이신가요? 이 페이지 상단에 노출하세요 — 30일 동안 $99 →
Study of INCA036978 in Participants With Myeloproliferative Neoplasms
피험자 모집 중1상
- University of Texas M. D. Anderson Cancer Center, Houston
A Phase 3 Study of Pelabresib (DAK539) and Ruxolitinib in Myelofibrosis (MF)
피험자 모집 중3상
- MD Anderson Cancer Center, Houston
A Phase 1 Study of LY5830966 in Participants With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (PPV-MF), or Post-Essential Thrombocythemia Myelofibrosis (PET-MF) Who Have Been Failed by a Type I JAK2 Inhibitor (JAK2i)
피험자 모집 중1상
- MD Anderson Cancer Center, Houston
A Study to Compare Elritercept to Placebo in Adults With Myelofibrosis and Anemia Who Are Taking Ruxolitinib
피험자 모집 중3상
- MD Anderson Cancer Center, Houston
- The University of Utah-Huntsman Cancer Institute, Houston
- LUMI Research, Houston
Study of Momelotinib in Combination With Luspatercept in Participants With Transfusion Dependent Myelofibrosis
피험자 모집 중2상
- GSK Investigational Site, Houston
A Phase 1 Study of PRT12396 in Participants With Select Myeloproliferative Neoplasms
피험자 모집 중1상
- The University of Texas, MD Anderson Cancer Center, Houston
A Study to Evaluate DMR-001 in Participants With CALR-mutant Myeloproliferative Neoplasms
피험자 모집 중1상
- Site US10, Houston
Study of DISC-0974 (RALLY-MF) in Participants With Myelofibrosis or Myelodysplastic Syndrome and Anemia
피험자 모집 중1/2상
- MD Anderson, Houston
Leading in MPNs Beyond Ruxolitinib in Combo With T-Regs
피험자 모집 중1상
- The University of Texas MD Anderson Cancer Center, Houston
Phase I/II Clinical Trial of Axatilimab, a CSF1R Monoclonal Antibody, in Combination With Ruxolitinib as Therapy for Patients With Myelofibrosis (MF) and Chronic Myelomonocytic Leukemia (CMML)
피험자 모집 중1/2상
- The University of Texas M. D. Anderson Cancer Center, Houston
A Study of Oral Nuvisertib (TP-3654) in Patients With Myelofibrosis
피험자 모집 중1/2상
- MD Anderson Cancer Center, Houston
High Dose Ruxolitinib and Allogeneic Stem Cell Transplantation in Myelofibrosis Patients With Splenomegaly
피험자 모집 중2상
- MD Anderson Cancer Center, Houston
Open Label Phase 1/2 Study of Tasquinimod in Patients With Primary Myelofibrosis (PMF), Post-Polycythemia Vera Myelofibrosis (Post-PV MF), or Post-Essential Thrombocytosis Myelofibrosis (Post-ET MF)
피험자 모집 중1/2상
- MD Anderson Cancer Center, Houston
Study of Oral Administration of LP-118 in Patients With Relapsed or Refractory CLL, SLL, MDS, MDS/MPN, AML, CMML-2, MPN-BP, ALL, MF, NHL, RT, MM or T-PLL.
피험자 모집 중1상
- MD Anderson Cancer Center, Houston
A Study to Evaluate INCA033989 Administered as a Monotherapy or in Combination With Ruxolitinib in Participants With Myeloproliferative Neoplasms
피험자 모집 중1상
- Md Anderson Cancer Center, Houston
A Platform Protocol to Investigate Post-Transplant Cyclophosphamide-Based Graft-Versus-Host Disease Prophylaxis in Patients With Hematologic Malignancies Undergoing Mismatched Unrelated Donor Peripheral Blood Stem Cell Transplantation
피험자 모집 중2상
- MD Anderson, Houston
A Study of Selinexor Monotherapy in Subjects With JAK Inhibitor-naïve Myelofibrosis and Moderate Thrombocytopenia
피험자 모집 중2상
- MD Anderson, Houston
SYNERGY-AI: Artificial Intelligence Based Precision Oncology Clinical Trial Matching and Registry
피험자 모집 중관찰 연구
- Massive Bio SYNERGY-AI site, Houston
Study of Navtemadlin add-on to Ruxolitinib in JAK Inhibitor-Naïve Patients With Myelofibrosis Who Have a Suboptimal Response to Ruxolitinib
피험자 모집 중3상
- U.T. MD Anderson Cancer Center, Houston
Study of TL-895 Combined With Ruxolitinib in JAKi Treatment-Naïve MF Subjects and Subjects With MF Who Have a Suboptimal Response to Ruxolitinib
피험자 모집 중1/2상
- The University of Texas MD Anderson Cancer Center, Houston
다른 도시의 골수섬유증 시험
- New York City, NY연구 21개
- Boston, MA연구 13개
- Durham, NC연구 13개
- Columbus, OH연구 12개
- Seattle, WA연구 12개
- Tampa, FL연구 11개
- Nashville, TN연구 11개
- Miami, FL연구 11개
- Salt Lake City, UT연구 11개
- Ann Arbor, MI연구 10개
- Atlanta, GA연구 10개
- Baldwin Park, CA연구 10개
Houston의 다른 연구
- 비소세포폐암연구 143개
- 유방암연구 126개
- 암 (전체)연구 124개
- 대장직장암연구 101개
- 전이성 암연구 100개
- 난소암연구 90개
- 급성 골수성 백혈병연구 88개
- 폐암연구 78개
- 전립선암연구 73개
- 자궁내막암연구 69개
- 흑색종연구 61개
- 췌장암연구 59개
ClinicalTrials.gov 출처, 2026. 11. 15. 기준 데이터입니다. 각 연구는 자체적인 자격 기준을 설정하며, 연구 팀이 참여자를 결정합니다.